Key statistics
On Friday, Traws Pharma Inc (TRAW:NAQ) closed at 4.46, 7.45% above its 52-week low of 4.16, set on Nov 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.60 |
---|---|
High | 4.65 |
Low | 4.36 |
Bid | 4.22 |
Offer | 5.50 |
Previous close | 4.51 |
Average volume | 7.29k |
---|---|
Shares outstanding | 3.03m |
Free float | 2.72m |
P/E (TTM) | -- |
Market cap | 13.65m USD |
EPS (TTM) | -141.34 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 20:05 GMT.
More ▼
- Traws Pharma Provides Business Update and Reports Q3 2024 Financial Results
- Traws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir Marboxil
- Traws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro Inhibitor
- Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors
- Traws Pharma, Inc. Announces Special Shareholders Meeting Results
- Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business Highlights
- Traws Pharma to Host Corporate Update Call on August 15, 2024, at 8:00 AM ET
- Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate
- Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update
- Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy
More ▼